SCHEMBL4450175

SCHEMBL4450175

N#Cc1ccc(-c2ccccc2-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.75
PTPN5 P54829 2/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP3A5 P20815 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PDK2 Q15119 1/20 0.47
CYP11B2 P19099 1/20 0.46
KDM1A O60341 3/20 0.44
DGAT1 O75907 1/20 0.44
SOAT1 P35610 1/20 0.44
KCNH2 Q12809 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456838 0.86 KIF11 (1.00) KIF11PTPN5PTGDR2CYP3A4CYP3A5
SCHEMBL13063632 0.86 KIF11 (1.00) KIF11PTPN5PTGDR2CYP3A4CYP3A5
SCHEMBL4450178 0.85 KIF11 (0.59) KIF11PTPN5PTGDR2ALDH1A1MAPT
SCHEMBL17840160 0.84 KIF11 (0.68) KIF11ALDH1A1KDM4ECYP1A2POLB
SCHEMBL31463164 0.84 TSHR (0.57) KIF11ALDH1A1PDK2CYP11B2MAOB
SCHEMBL524351 0.84 KIF11 (0.86) KIF11PTPN5PTGDR2CYP3A4CYP3A5
SCHEMBL8025255 0.82 KIF11 (0.65) KIF11PTGDR2ALDH1A1KDM4ECYP1A2
Hydrochloric Acid SCHEMBL27812058 0.82 KIF11 (0.83) KIF11PTPN5PTGDR2CYP3A4CYP3A5
SCHEMBL6561038 0.81 PTPN5 (0.67) KIF11PTPN5ALDH1A1MAPTSMN1; SMN2
SCHEMBL12295373 0.81 AR (0.63) KIF11PTPN5PDK2CYP11B2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507830-B2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles PHARMACORE, INC. (US) 2009-03-24 US disclosed
US-6962999-B2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles PHARMACORE, INC. (US) 2005-11-08 US disclosed
US-20050124808-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM I.P. ASSETS B.V. (NL) 2005-06-09 US disclosed
US-20030100760-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM N.V. (NL) 2003-05-29 US disclosed
EP-1279656-A2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM N.V. (NL) 2003-01-29 EP disclosed
US-6194599-B1 Process for preparing biaryl compounds CATALYTICA, INC. 2001-02-27 US disclosed
US-5922898-A Process for preparing biaryl compounds CATALYTICA PHARMACEUTICALS, INC. (US) 1999-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100760-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles AHR, PAH, DDT KIF11 2492/4885PTPN5 203/4885PTGDR2 4018/4885
US-20050124808-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles AHR, PAH, DDT KIF11 2492/4885PTPN5 203/4885PTGDR2 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.